Alerts on Melt Pharmaceuticals reporting results for a late-stage clinical trial of its sedative drug was incorrectly tagged and sourced to Harrow Inc , its former parent.
Melt was spun out from Harrow as a separate entity in 2019.
For the correctly tagged alerts, click
STORY_NUMBER: nTUABCPB7Q STORY_DATE: 20/11/2024 STORY_TIME: 12:00:16 PM GMT
((Bangalore.newsroom@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.